LUNG · Pulmonx Corp
$1.17
-0.05 (-4.10%)
At close · Jul 24
Market Cap
$49.42M
Shares
42.24M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Glendon French | CEO | $3,543,520 |
| Derrick Sung | CFO | $2,951,391 |
| Mehul Joshi | CFO | $1,983,761 |
| David Lehman | General Counsel | $1,710,404 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Steven S. Williamson | CEO | $5,234,479 |
| Mehul Joshi | CFO | $3,244,400 |
| David Lehman | General Counsel | $1,485,132 |
| Glendon French | CEO | $330,786 |
| Derrick Sung | CFO | — |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Glendon French | CEO | $5,795,297 |
| Derrick Sung | CFO | $2,676,860 |
| David Lehman | General Counsel | $2,639,100 |
| Geoffrey Beran Rose | Chief Commercial Officer | $1,957,816 |
| Mehul Joshi | CFO | — |
| Steven S. Williamson | CEO | — |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Glendon French | CEO | $4,565,019 |
| David Lehman | General Counsel | $2,204,375 |
| Geoffrey Beran Rose | Chief Commercial Officer | $2,193,063 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Glendon French | CEO | $4,812,494 |
| General Counsel | — | $2,077,068 |
| David Lehman | General Counsel | $2,077,068 |
| Geoffrey Beran Rose | Chief Commercial Officer | $2,032,914 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Glendon French | CEO | $3,373,436 |
| General Counsel | — | $1,364,788 |
| David Lehman | General Counsel | $1,364,788 |
| Geoffrey Beran Rose | Chief Commercial Officer | $817,881 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Glendon French | CEO | $1,122,487 |
| Geoffrey Beran Rose | Chief Commercial Officer | $473,307 |
| General Counsel | — | — |